Duriez P R, Adamantidis M M, Rouet R H, Libersa C C, Dupuis B A
J Pharmacol. 1984 Jul-Sep;15(3):331-51.
Antiarrhythmic and cardioprotective effects of propranolol and sotalol were examined by studying their action on cellular electrical activity (recorded using standard microelectrode techniques) and creatine-kinase leakage (measured in the effluent from the experimental bath chamber) in the in vitro guinea-pig left ventricular myocardium exposed to conditions mimicking severe or moderate ischemia. Returning the tissue to the normal conditions was considered as equivalent to ischemic-heart reperfusion. Propranolol (2 X 4 mg/kg) was intraperitoneally administered to guinea-pigs, daily for 21 days. It was perfused in vitro (1.10(-6) M) during the whole experiments. Propranolol decreased action potential duration in control conditions (p less than 0,05), precipitated the occurrence of inexcitability during severe ischemia (p less than 0,01) and improved the recovery of cellular excitability during reperfusion. Propranolol did not significantly affect the creatine-kinase leakage during ischemia and reperfusion.
通过研究普萘洛尔和索他洛尔对豚鼠左心室心肌细胞电活动(采用标准微电极技术记录)以及肌酸激酶泄漏(在实验浴槽流出液中测量)的作用,检测了它们在模拟重度或中度缺血条件下的抗心律失常和心脏保护作用。将组织恢复到正常条件被视为等同于缺血性心脏再灌注。将普萘洛尔(2×4mg/kg)腹腔注射给豚鼠,每日一次,共21天。在整个实验过程中,以体外灌注(1×10⁻⁶M)。普萘洛尔在对照条件下缩短动作电位时程(p<0.05),在重度缺血时促使兴奋性丧失的发生(p<0.01),并改善再灌注期间细胞兴奋性的恢复。普萘洛尔对缺血和再灌注期间的肌酸激酶泄漏无显著影响。